Study of SHR-9839 with other treatments for solid tumors
Part of Cancer clinical trials.
This study tests a new drug called SHR-9839 given under the skin, combined with other anti-cancer treatments, for people with solid tumors. The goal is to see if it is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You are generally able to care for yourself (ECOG score 0 or 1).
- You have a tumor that can be measured on scans and you can provide a tissue sample from a prior biopsy or surgery.
- You do not have active cancer that has spread to the brain or the lining of the brain.
- You do not have a history of another cancer in the past 3 years (except for certain early-stage cancers).
- You do not have serious heart, lung, or immune system problems, or active infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, SHR-4685, for people with solid tumors that are measurable. It aims to see if the drug is safe and how your body processes it.
This trial tests a new drug called SHR-7367 combined with other cancer medicines for people with solid tumors. It aims to see if the combination is safe and effective.
This study tests an experimental drug called SHR-4595 given as a shot (injection) to people with advanced solid tumors. The goal is to see if it is safe and how the body handles it, which might help shrink tumors or slow their growth.
This Phase 1 trial studies SHR-9839, a new injection medicine, for people with advanced solid tumors that can’t be removed by surgery and have returned or stopped responding to standard care. It mainly aims to find a safe dose and see early signs of whether the treatment can work.
This study is testing a new drug called SHR-1049 for people with advanced solid tumors (cancers that have spread). It looks at safety, how the drug moves through the body, and whether it helps shrink tumors. You may be eligible if you have tried standard treatment without success or no standard treatment exists.
This trial tests a new drug called SHR-9839 combined with other cancer treatments for people with advanced solid tumors, including a certain type of lung cancer. The goal is to see if the combination is safe and effective against the cancer.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.